Thakur Gurjeet Singh
Thakur Gurjeet Singh is an expert in Pharmacy at Chitkara University (India). As of October 2026, ScienceLeadR ranks Thakur Gurjeet Singh in the top 1% of experts in India for Alzheimer Disease, Dementia and Neurocognitive Disorders. Thakur Gurjeet Singh has authored 518 publications, the most recent in 2026. SLR score: 2,115 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties: Neurology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 518
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| From Acidochromism to Device Fabrication: A DFT-Backed Chemosensor for Portable Co²⁺ and Cu²⁺ Sensing. PMID 42944956 | J Fluoresc | 2026 | 0 |
| Recent advances in scaffold-based KRAS G12C inhibitors: SAR and biological evaluation insights. PMID 42936580 — cells, neoplasms, carcinoma, non-small-cell lung, therapeutics, mutation, pyrimidines | RSC Med Chem | 2026 | 0 |
| Neolignans as emerging anticancer leads: Isolation, chemical diversity, structure-activity relationships. PMID 42784935 — cells, drug development, pharmaceutical preparations, structure-activity relationship, chemistry, pharmaceutical, pharmacology | Eur J Med Chem | 2026 | 0 |
| Mechanistic Evaluation of Psilocybin in Neurodegenerative Disorders: Relevance of 5-HT2A Receptors and Downstream Pathways. PMID 42895147 — depression, sclerosis, dementia, neuronal plasticity, safety, alzheimer disease, pharmaceutical preparations, psilocybin, therapeutics, neurodegenerative diseases, cognition | CNS Neurol Disord Drug Targets | 2026 | 0 |
| Wound Healing Potential of Multifunctional Nanomaterials: Mechanism, Future Prospects, and Challenges. PMID 42797230 — re-epithelialization, cells, cell proliferation, safety, protein kinases, nanoparticles, nanostructures, therapeutics, tissues, angiogenesis | Pharmaceutics | 2026 | 0 |
LeadR Networks
Main global connection map